Surgical options in the treatment of hepatic metastasis from colorectal cancer

scientific article published on May 1995

Surgical options in the treatment of hepatic metastasis from colorectal cancer is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0011-3840(05)80012-7
P8608Fatcat IDrelease_fce4yesjabc2fmj3bdfede4sty
P698PubMed publication ID7538062

P2093author name stringFong Y
Blumgart LH
P2860cites workRole of staging laparoscopy in the treatment of hepatic malignancyQ72780190
Regional hepatic chemotherapy using an implantable drug infusion pumpQ72781212
Newer anatomy of the liver and its variant blood supply and collateral circulationQ72795487
Regional chemotherapy of colorectal cancer metastatic to the liverQ72804504
Repeat hepatic resections for metastatic colorectal cancerQ72854631
The role of hepatic artery ligation and dearterialization with infusion chemotherapy in advanced malignancies in the liverQ72873109
Cancer of the colon and rectum; statistical study, with end-resultsQ74090789
THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUMQ77085850
Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuitQ78368402
Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factorsQ93589861
High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcomaQ33374154
Large hepatocellular cancers: hepatic resection or liver transplantation?Q34486983
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trialQ34665442
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trialQ34683968
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastasesQ34684005
Resection of hepatic and pulmonary metastases from colorectal cancerQ35242914
Retinoids and cancer preventionQ35706195
New surgical treatments for recurrent colorectal cancerQ36557977
Surgical therapy for recurrent liver metastases from colorectal cancerQ38086818
Regional treatment of hepatic metastases and hepatocellular carcinomaQ38285480
Hepatic resection for metastases from colorectal carcinoma is of dubious valueQ38687015
Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumorsQ39568831
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysisQ39809322
Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatomaQ40005183
Survival after liver resection for secondary tumorsQ40124764
Intermittent occlusion of the hepatic artery and infusion chemotherapy for carcinoma of the liverQ40156358
Resection of 'recurrent' colorectal metastases to the liverQ40739520
Repeat hepatectomy for cancerQ40809888
Repeat liver resection for recurrent colorectal metastasesQ40896092
5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer.A southwest oncology group studyQ40942460
Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectumQ41454484
Effect of haemodilution on transfusion requirements in liver resectionQ41972843
Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusionQ41980074
Repeated hepatic resection for recurrent metastases from colorectal cancerQ42065338
Resectability of large focal liver lesionsQ42113004
Bile duct obstruction: radiologic evaluation of level, cause, and tumor resectabilityQ43474685
Intraoperative ultrasonographic study of the liver. Methods and anatomic resultsQ43514160
A new technique for hepatic infusional chemotherapyQ43650292
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinantsQ43681655
Postoperative albumin infusion therapy based on colloid osmotic pressure. A prospectively randomized trialQ43752304
Prognosis of carcinoma of the large bowel in the presence of liver metastasesQ43778264
Palliative operative management in rectal carcinomaQ43782302
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trialQ43909975
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinomaQ43967077
Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trialQ43972355
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural historyQ43990247
Surgical Treatment of Hepatic Metastases From Colorectal CancersQ44036688
Bacterial translocation after major hepatectomy in patients and ratsQ44064538
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastasesQ44102151
Recurrence of colorectal cancer after hepatic resectionQ44373201
Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinomaQ44438635
Resection of hepatic metastases from colorectal cancerQ44454061
Survival of patients at pennsylvania hospital with hepatic metastases from carcinoma of the colon and rectumQ44892599
Hepatic resection of metastatic colorectal carcinoma: a ten-year experienceQ44955801
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusionQ46046419
A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liverQ47575070
Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapyQ47577784
Results of extensive surgery for liver metastases in colorectal carcinomaQ48553037
Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases.Q51763749
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.Q52103890
Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence.Q52535226
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.Q52693985
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.Q52869426
Extended left hepatectomy: Technical aspects of an evolving procedureQ61812899
Subtotal hepatectomy: A new procedure based on the inferior right hepatic veinQ61812922
Cytotoxic perfusion for colorectal liver metastasesQ67273834
Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group studyQ67485670
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinomaQ67568286
A 5-Year Study of Cryosurgery in the Treatment of Liver TumorsQ67909107
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastasesQ67938409
Inhibiting IL-6 in human multiple myelomaQ67997982
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastasesQ68109746
A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinomaQ68130657
Technique of hepatic vascular exclusion for extensive liver resectionQ68139553
Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary resultsQ68189530
Resection of synchronous liver metastases from colorectal cancerQ68196363
Effect of hepatic cryotherapy on serum CEA concentration in patients with multiple inoperable hepatic metastases from colorectal cancerQ68197193
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trialQ68424140
Cryoprobe as a "handle" for resection of metastatic liver tumorsQ68619056
Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liverQ68706752
Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancerQ68885029
Nitrogen embolus as a complication of hepatic cryosurgeryQ68919625
Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastasesQ68983668
Apparent extra-hepatic invasion by metastatic tumours in the liverQ69208339
Pattern of recurrence in liver resection for colorectal secondariesQ69254621
Cryotherapy for liver metastases: a new approachQ69559563
Pathological changes in the liver and computed tomographyQ69579738
Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patientsQ69777525
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approachQ69777529
Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primariesQ69985299
Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liverQ70023425
Major hepatic resection for metachronous metastases from colon cancerQ70056690
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survivalQ70056694
Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidityQ70366970
Surgical anatomy and anatomical surgery of the liverQ70386490
Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgeryQ70386505
Venous bypass in clinical liver transplantationQ70386801
Liver resection under total vascular isolation. Variations on a themeQ70539952
Natural history of patients with untreated liver metastases from colorectal cancerQ70750008
Hepatic artery ligation for liver metastasis in colorectal carcinomaQ71256283
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resectionQ71289337
Experience with total vascular isolation of the liverQ72099997
The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomyQ72334006
Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastasesQ72688564
Blood transfusions and prognosis in colorectal cancerQ72733492
One hundred consecutive hepatic resections. Blood loss, transfusion, and operative techniqueQ72766280
P433issue5
P921main subjectcolorectal cancerQ188874
P304page(s)333-421
P577publication date1995-05-01
P1433published inCurrent Problems in SurgeryQ15754613
P1476titleSurgical options in the treatment of hepatic metastasis from colorectal cancer
P478volume32

Reverse relations

cites work (P2860)
Q335006799-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.
Q34998417An audit of results of a no-drainage practice policy after hepatectomy
Q50135642Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?
Q73154473Applications of electrosurgery: radio frequency ablation of liver tumors
Q78530308Arantius' ligament approach to the left hepatic vein and to the common trunk
Q83300057Assessment of risk-independent follow-up to detect asymptomatic recurrence after curative resection of colorectal cancer
Q71973106Cancer surgery in the elderly
Q55180937Colorectal surgery as a specialty.
Q79247725Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients
Q34986203Complications following liver resection for colorectal metastases do not impact on longterm outcome
Q36633285Cryosurgery in the treatment of liver metastasis from colorectal cancer
Q44079762Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus
Q41109673Evaluation of the solid hepatic mass
Q50149339Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial
Q47715523Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome
Q50504421Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: mediation by cytochrome c release.
Q73924199Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer
Q41416843Invasive therapy of metastatic colorectal cancer to the liver
Q79922197Is extended hepatectomy for hepatobiliary malignancy justified?
Q34625619Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis.
Q84331533Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease
Q54373557MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.
Q77495176Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival
Q71779419Pancreatic or liver resection for malignancy is safe and effective for the elderly
Q74776352Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation
Q36610761Predictors of survival after hepatic resection among patients with colorectal liver metastasis
Q47721142Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study
Q77983517Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients
Q74457737Reduction of transfusion requirements during major hepatic resection for metastatic disease
Q77620908Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions
Q53823544Selecting incision-dominant cases for robotic liver resection: towards outpatient hepatectomy with rapid recovery.
Q34346192Surgical management of hepatic metastases from colorectal malignancies.
Q37715123Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis
Q39878611Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial
Q52220229Theoretical design of a spherically sectioned phased array for ultrasound surgery of the liver.
Q51786105Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.
Q74725121Use of preoperative autologous blood donation in liver resections for colorectal metastases
Q73480205Useful stapling techniques in liver surgery